A flow-injection biamperometric method for determination of pantoprazole in pharmaceutical tablets.
A flow-injection biamperometric method for determination of pantoprazole (PTZ) in pharmaceutical tablets is reported for the first time. The reversible redox couples Fe3+/Fe2+, Fe(CN)6(3-)/Fe(CN)6(4-), Ce4+/Ce3+, VO3(-)NO2+, and I2/I- were tested as indicating redox systems for biamperometric determination of PTZ in a flow-injection assembly with optimized flow parameters. The best results were obtained using V03(-)NO2+, which showed to be a selective and sensitive biamperometric indicating system for PTZ even in the presence of excipients and antioxidants that typically are found in drugs. The analytical graph was linear (r = 0.99945) in the range from 10 to 100 mg/L using 25 mmol/L VO3(-) as the reagent and water as the carrier stream and applying 100 mV between the 2 platinum wire electrodes. The limits of detection and quantitation were 200 and 667 microg/L, respectively, with a sensibility of calibration of 22.6 mV/mg/L. The proposed method was successfully applied to determine PTZ in commercial pharmaceutical tablets with a mean relative error of 1.60% (n = 5) and mean relative standard deviation of 3.10%. Recoveries close to 100% showed good agreement between the expected amount of PTZ in tablets (40 mg) and the results found by the application of the proposed method and demonstrated that the formulations used in the tablet compositions do not interfere in the PTZ analysis. The system had good stability, with a relative standard deviation of 3.80% for 9 sequential injections of a 60 mg/L PTZ solution. A sampling rate of about 100 samples/h was obtained.
Castro
Suzana L
SL
Universidade Federal da Paraíba, Departamento de Química, CCEN, 58059-900, João Pessoa, PB, Brazil.
Neto
Osmundo D Pessoa
OD
Santos
Sergio R B
SR
Medeiros
Everaldo P
EP
Lima
Ricardo A C
RA
Martins
Valdomiro L
VL
Araújo
Mario C U
MC
Josué
C C Santos
CC
Korn
Mauro
M
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents / Q000032:analysis; D001562:Benzimidazoles / Q000032:analysis*; D002138:Calibration; D002623:Chemistry Techniques, Analytical / Q000379:methods*; D002626:Chemistry, Pharmaceutical / Q000379:methods; D004563:Electrochemistry / Q000379:methods*; D004566:Electrodes; D017022:Flow Injection Analysis / Q000379:methods; D008956:Models, Chemical; D009853:Omeprazole / Q000031:analogs & derivatives* / Q000032:analysis; D010084:Oxidation-Reduction; D000077402:Pantoprazole; D011522:Protons; D015203:Reproducibility of Results; D013454:Sulfoxides / Q000032:analysis*; D013607:Tablets; D013678:Technology, Pharmaceutical / Q000295:instrumentation / Q000379:methods
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D001562:Benzimidazoles; D011522:Protons; D013454:Sulfoxides; D013607:Tablets; D000077402:Pantoprazole; D009853:Omeprazole